<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Delayed cerebral vasospams is caused by excessive accumulation of <z:chebi fb="40" ids="18243">dopamine</z:chebi>-beta-hydroxylase (DBH) and <z:chebi fb="15" ids="33569">noradrenaline</z:chebi> in cerebral vessel walls </plain></SENT>
<SENT sid="1" pm="."><plain>This study demonstrates the mechanisms of delayed spasm, particularly the role of red blood cell components, and the successful relief of delayed <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Spasmogenic substances which contained a <z:chebi fb="4" ids="30413">heme</z:chebi> component, such as methemoglobin, methemalbumin and catalase enhanced DBH activity in human serum as measured by a one step chemical spectrophotometric assay </plain></SENT>
<SENT sid="3" pm="."><plain>The concentration which gave the highest DBH activity caused the maximum constriction of the basilar artery, when the substances were applied topically </plain></SENT>
<SENT sid="4" pm="."><plain>Among components of red cells, methemoglobin, methemalbumin, catalase and <z:chebi fb="0" ids="17154">nicotinamid</z:chebi> <z:chebi fb="0" ids="16708">adenin</z:chebi> <z:chebi fb="0" ids="47885">dinucleotide</z:chebi> (<z:chebi fb="0" ids="16908">NADH</z:chebi>) caused constriction of basilar artery in cats, when applied topically, whereas <z:chebi fb="0" ids="36161">hematin</z:chebi>, <z:chebi fb="0" ids="50385">hemin</z:chebi> and <z:chebi fb="0" ids="16990">bilirubin</z:chebi> caused no significant spasm </plain></SENT>
<SENT sid="5" pm="."><plain>An <z:chebi fb="0" ids="7861">oxyhemoglobin</z:chebi> solution obtained by mixture with methemoglobin and <z:chebi fb="6" ids="22652,29073">ascorbic acid</z:chebi> produced no significant vascular spasm either </plain></SENT>
<SENT sid="6" pm="."><plain>Relief of delayed <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> was obtained with topical application of specific alpha adrenergic blocking drug such as phenoxybenzamine, specific inhibitors of DBH such as fusaric acid, o-<z:chebi fb="2" ids="36417">phenanthroline</z:chebi> and alphaalpha' dipyridyl beta2 adrenergic stimulants such as <z:chebi fb="1" ids="2549">salbutamol</z:chebi>, and a <z:chebi fb="0" ids="50218">phosphodiesterase inhibitor</z:chebi>, <z:chebi fb="6" ids="22652,29073">ascorbic acid</z:chebi> </plain></SENT>
</text></document>